BIRC6 and cancer: Recent studies show that BIRC6 is increased in a number of intractable human cancers, including de novo acute myeloid leukemia, breast cancer, ovarian cancer, hepatic cancer, prostate cancer, colon cancer, neuroblastoma, and non-small-cell lung cancer where it may contribute to cancer cell survival and proliferation [19,21,23,45,52–55].